Accelmed Partners completed the acquisition of the advanced rehabilitation business from Bioventus for $45m.

Accelmed Partners, a private equity firm, completed the acquisition of the advanced rehabilitation business from Bioventus, a medical device company, focuses on developing and commercializing treatments, for $45m. “We are excited to welcome the Advanced Rehabilitation business of Bioness to our investment portfolio. We believe Bioness’ Advanced Rehabilitation products are critical for helping patients with stroke and other neuromuscular conditions in their rehabilitation journey. We believe that there is a significant opportunity for growth and intend to invest in developing and extending the product line to continue improving patients’ lives,” Uri Geiger, Accelmed Managing Partner.